Promoting Resilience in Stress Management Intervention for Women with Early Stage or Metastatic Breast Cancer
This clinical trial tests the impact of the Promoting Resilience in Stress Management (PRISM) intervention for women with breast cancer that has not spread beyond the breast and the axillary lymph nodes (early stage) or has spread from where it first started (primary site) to other places in the body (metastatic). Patients with breast cancer often deal with persistent psychological (mental and emotional) distress. Fear of recurrence (cancer that has come back after a period of improvement) is associated with difficulties in performing daily and social activities, higher depression and anxiety, and lower quality of life. The PRISM intervention is an evidence-based program that builds resilience (ability to cope mentally and emotionally with a challenging life experiences). This program uses centrally-administered skills-based coaching to bolster positive psychological tools known as resilience resources. These resources include stress management, goal-setting, and positive reframing. This study may help researchers learn how the PRISM intervention may improve resilience and psychological distress for women with early stage or metastatic breast cancer.